HPO Completes Amendment Report Submission... "Pursuing KOSDAQ Listing in May"

[Asia Economy Reporter Jang Hyowon] HPO announced on the 5th that it has completed the submission of the amended securities registration statement and will begin the public offering process to pursue a KOSDAQ listing in May.

HPO completed the preparation of the amended registration statement in response to the Financial Supervisory Service's correction request and disclosed the statement on the 2nd. Since the securities registration statement takes effect 15 business days after submission, the demand forecast dates have been changed to April 27-28, and the subscription dates have been changed to May 3-4.

During the extended period, HPO plans to conduct broader investor meetings to introduce the company to many investors.

Premium health supplement brand Denps.

HPO's desired public offering price band is 22,200 to 25,400 KRW per share, with 3,987,632 shares to be offered. The expected public offering amount is between 88.5 billion and 101.3 billion KRW, and the estimated market capitalization is approximately 440 billion to 500 billion KRW.

HPO operates a health functional business centered on the high-end premium brand ‘Denps’ not only in the domestic market but also in European and Asian markets.

Last year’s performance recorded consolidated sales of 142.8 billion KRW and operating profit of 25.7 billion KRW. Over the past three years, sales growth rate was 71.6%, maintaining a steep growth trend, while profitability was excellent with an operating profit margin exceeding 18%. The main growth drivers are the probiotic ‘Denmark Yusangyun Iyagi’ and vitamin ‘Truevitamin,’ and recently, sales of other products such as omega-3, lutein, and collagen have also increased simultaneously.

Along with growth in the domestic market, plans for active overseas market expansion are underway. To this end, global key talents have been secured, including ‘Lasse Nagell,’ Vice President of Christian Hansen, the world’s No. 1 probiotic company, appointed as head of the Denmark branch, and Yoon Yeonjeong, head of Korea Human Nutrition at DSM, the world’s No. 1 vitamin raw material company, appointed as head of global marketing.

This content was produced with the assistance of AI translation services.